Nacuity Pharmaceuticals Appoints Robert R. Ruffolo, Ph.D., to Board of Directors

NEXT STORY
Global Hospital Acquired Infection Control Market Report 2021: Single-Use Medical Nonwovens and Devices Presents Opportunities
PREV STORY
Yamana Gold Repurchases an Additional 1,584,500 Common Shares Under Its Share Repurchase Program for a Cumulative Total of 3,321,276 Common Shares for Approximately C$18 Million
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novartis JULIET trial of Kymriah demonstrates more than one-year durability of responses in adults with relapsed or refractory DLBCL

Overall response rate was 52% and median duration of response was not reached at ...

author_avatar
NASDAQ Market News

BioNTech Appoints Dr. Özlem Türeci as Chief Medical Officer

MAINZ, Germany, May 29, 2018 (GLOBE NEWSWIRE) -- BioNTech AG, a fully-integrated biotechnology company ...

author_avatar
NASDAQ Market News

Galena Biopharma Announces Pricing of Registered Direct Offering

SAN RAMON, Calif., July 08, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a ...

author_avatar
NASDAQ Market News